MedNews

  • Drug Industry News
  • FDA News & Alerts
  • Health & Medical News
You are here: Home / FDA News & Alerts / FDA Warning on Sleep Medications: Ambien, Lunesta, Restoril, Others

FDA Warning on Sleep Medications: Ambien, Lunesta, Restoril, Others

March 15, 2007 By MedNews Leave a Comment

The FDA has issued stronger warnings on sleep medications, such as Ambien, Lunesta, and Restoril, and has asked the drugs manufacturers to place stronger warnings on the package labels.

The agency cites concerns such as allergic reactions, and sleep walking and "sleep driving" in its statement.

Source: Food and Drug Administration (FDA)
P07-45

Filed Under: FDA News & Alerts, Sleep Tagged With: ambien, fda, lunesta, restoril, sleep



Leave a Reply

Your email address will not be published. Required fields are marked *

Search



Tag Cloud

alcohol allergies alzheimers antibiotics breast cancer cancer Centers for Disease Control (CDC) children cholesterol dementia depression Diabetes diet drug abuse exercise fda flu food genetics geriatrics h1n1 heart heart attack heart disease high blood pressure HIV/AIDS hormone therapy hypertension lungs menopause NIH obesity pain pediatrics pregnancy prostate cancer seniors sleep smoking statistics stroke sun teens USA women's health

Recent Comments

  • Mia Fritz on Health Benefits of Dark Chocolate
  • Shilpa on Why Too Much Iron Can Be Dangerous
  • Racheal on Teen Pregnancy May Be Reduced by Sex Education in Schools, Says Study
  • Don on Prilosec, Nexium and Prevacid Tied to Higher Risk of Pneumonia
  • Meso on Brain Changes in Elderly Can Affect Mobility and Balance
  • About Us
  • Contact

Copyright © 2025 Mednews ยท Log in